StockMarketWire.com - Allergy Therapeutics chief executive Manuel Llobet and finance director Ian Postlethwaite have been granted 624,024 and 312,012 nil cost options each respectively under the company's long term incentive plan.


At 8:32am: [LON:AGY] Allergy Therapeutics PLC share price was +0.01p at 31.13p



Story provided by StockMarketWire.com